OnabotulinumtoxinA is a well tolerated and effective treatment for refractory overactive bladder in real-world practice

INTRODUCTION AND HYPOTHESIS: In randomized clinical trials onabotulinumtoxinA was demonstrated to be an effective and well-tolerated treatment for overactive bladder (OAB) with urinary incontinence (UI). However, data reporting onabotulinumtoxinA use in everyday clinical practice are limited. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamid, Rizwan, Lorenzo-Gomez, Maria-Fernanda, Schulte-Baukloh, Heinrich, Boroujerdi, Amin, Patel, Anand, Farrelly, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788019/
https://www.ncbi.nlm.nih.gov/pubmed/32719964
http://dx.doi.org/10.1007/s00192-020-04423-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788019/
https://www.ncbi.nlm.nih.gov/pubmed/32719964
http://dx.doi.org/10.1007/s00192-020-04423-0

Ejemplares similares